Regulation of the Complement Receptor Type 2 (CR2/CD21) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus.

  • Ulgiati, Daniela (Chief Investigator)
  • Abraham, Lawrie (Chief Investigator)
  • Hollingsworth, P. (Chief Investigator)

Project Details

StatusFinished
Effective start/end date1/01/0431/12/04

Funding

  • Arthritis Foundation of WA